approved EB-2 (NIW) RFE Issued
Others
Pharmaceuticals · China · 2025-04-22
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.
Proposed Endeavor
The petitioner proposes to analyze biomedical and clinical data to advance drug development and data-driven medical decisions. The work focuses on designing clinical trials and statistical frameworks for serious health challenges such as cancer and oral disease. This endeavor aims to optimize treatment outcomes and enhance public health interventions through innovative biostatistical methods.
Why This Petition Was Approved
The petition was approved based on the petitioner's PhD and a record of 15 peer-reviewed journal articles, including 2 first-authored papers, which garnered 82 citations. The case was supported by 4 expert recommendation letters and evidence of 2 peer reviews for esteemed journals. These metrics, along with evidence of funding from major U.S. public health institutions, satisfied the Dhanasar criteria for national importance and being well-positioned.
Similar Cases
Management Consultant
Information Technology
WeGreened EB-2 (NIW) approved
2026-03-15
The petitioner proposes to continue their work in enterprise technology transformation, governance, and large-scale operational strategy. The work focuses on enhancing enterprise resilience, cybersecurity alignment, and digital transformation within major organizations to improve high-stakes operational settings.
Researcher
Healthcare
WeGreened EB-2 (NIW) approved
3 days 2026-03-02
The petitioner proposes to combine advanced clinical training with research to improve minimally invasive and reconstructive approaches for complex facial and nerve injuries. The work focuses on reducing downstream functional impairment and the overall care burden for patients.
Others
Information Technology · China
WeGreened EB-2 (NIW) approved
317 days 2026-02-21
The petitioner proposes to develop advanced deep learning models to improve the understanding of structure-function relationships in large biomolecules. This work aims to enable more accurate target identification, better candidate design, and more efficient therapeutic optimization for complex diseases. The endeavor specifically targets bottlenecks in drug development to reduce the high failure rate and cost of new drug candidates.
Research Assistant
Healthcare · China
WeGreened EB-2 (NIW) approved
California 30 days 2026-01-30
The petitioner proposes to use large-scale population datasets, cancer registries, and modern modeling tools, including AI, to identify healthcare and biological determinants of cancer outcomes and disparities. Her work focuses on building statistical and computational frameworks that connect real-world data to clinical decisions, specifically identifying barriers to delayed diagnosis and gaps in care. The goal is to translate these findings into evidence-based strategies for cancer prevention, early detection, and survivorship care.
Frequently Asked Questions
A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.
Browse More Cases
Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-04-22.
Browse all casesAt a Glance
Outcome approved
Processing 655 days
RFE Issued
EB-2 (NIW) Case Data
Scraped Case Data
Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671
Related Pages
Get Case Insights
Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.
Join Waitlist